(2020) Association of catechol-O-methyltranferase 472G>A (Val158Met) polymorphism with susceptibility to fibromyalgia syndrome. Journal of Orthopaedics. pp. 257-260.
Full text not available from this repository.
Abstract
Abstract Background:Several lines of research have suggested that the 472G > A (Val158Met) polymorphism at Catechol-O-methyltranferase (COMT) gene is implicated in the pathophysiology of FMS. Here, we have evaluated the association of COMT 472G > A polymorphism with risk of FMS. Methods:In this study 250 patients with FMS and 250 healthy controls were evaluated for COMT 472G > A polymorphism by RFLP-PCR assay. Results:There were no significant differences in the allele and genotype frequencies of COMT 472G > A polymorphism between FMS cases and healthy controls. Conclusions:Our results suggested that the COMT 472G > A polymorphism may not be risk factor for development of FMS.
| Item Type: | Article |
|---|---|
| Page Range: | pp. 257-260 |
| Journal or Publication Title: | Journal of Orthopaedics |
| Volume: | 20 |
| Depositing User: | ms soheila Bazm |
| URI: | http://eprints.ssu.ac.ir/id/eprint/11312 |
Actions (login required)
 |
View Item |